NASDAQ:NSPH (NSPH) (NSPH) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free NSPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$1.69▼$1.6950-Day Range N/A52-Week Range$0.48▼$3.64VolumeN/AAverage Volume886,293 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (NSPH) alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About (NSPH) Stock (NASDAQ:NSPH)Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). NSPH Stock News HeadlinesApril 22, 2024 | msn.comChris Stewart endorses 3rd Congressional District candidateApril 22, 2024 | msn.comOlive oil: alternatives for the 'liquid gold'April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 13, 2023 | msn.comLIVE FEED: Police, Correctional Services give update on Thabo Bester, Dr Nandipha Magudumana’s arrestsMarch 8, 2023 | msn.comMichelle Yeoh deletes post some saw as a slam on fellow Oscar nominee Cate BlanchettDecember 29, 2022 | msn.comTitans' Teair Tart takes a spill trying to celebrate fumble vs. CowboysDecember 17, 2022 | msn.comPolls open in Tunisian parliamentary election boycotted by oppositionDecember 17, 2022 | msn.comTop 10 customer hacks making workers’ lives miserableApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.November 21, 2022 | msn.comSan Mateo: After 40 years, Windy City restaurant, Da Bears fan hangout closes todayAugust 20, 2022 | thestreet.com8 Stocks Under $10 Surging HigherAugust 18, 2022 | msn.comNitish Kumar snubs BJP’s ‘jungle raj returns’ allegation, says will respond at an appropriate timeAugust 6, 2022 | msn.comMore afternoon downpours and storms SundayDecember 14, 2021 | usnews.comLogic's Hit '1-800-273-8255' May Have Saved American LivesSee More Headlines Receive NSPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2016Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:NSPH CUSIPN/A CIK1105184 Webwww.nanosphere.us Phone+1-847-4009000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report NSPH Stock Analysis - Frequently Asked Questions How were (NSPH)'s earnings last quarter? (NSPH) (NASDAQ:NSPH) announced its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.59) by $0.04. The medical research company earned $6.60 million during the quarter, compared to analysts' expectations of $6.50 million. The company's revenue for the quarter was up 43.5% on a year-over-year basis. During the same period in the prior year, the company posted ($1.29) earnings per share. What other stocks do shareholders of (NSPH) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), Molecular Templates (MTEM), Northwest Biotherapeutics (NWBO), Sarepta Therapeutics (SRPT), XOMA (XOMA), Cypress Semiconductor (CY) and Equity Bancshares (EQBK). This page (NASDAQ:NSPH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NSPH) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
